We had a brilliant #NephJC discussion on ISPD 2020 recommendations yesterday!
To commemorate this day, here's a small compilation of some important PD studies -
CANUSA
CANUSA Re-analysis
ADEMEX
HONGKONG TRIAL
EAPOS
NECOSAD 2
NECOSAD
CCr = creatinine clearance
pCCr = peritoneal creatinine clearance
5L/wk 🔽 CCr ➡️ 7% 🔼RR of death
◼️ Gave target weekly Kt/V = 2.1 and CCr = 70L/wk
❗ ASSUMED pCCr = Residual kidney CCr
ncbi.nlm.nih.gov/pubmed/8785388
◼️ pCCr ➡️NO INFLUENCE on survival
◼️ 250 mL/day🔼urine output ➡️36%🔽RR of death
ncbi.nlm.nih.gov/pubmed/11562415
◼️pCCr ➡️NO INFLUENCE on survival
ncbi.nlm.nih.gov/pubmed/11961019
2️⃣ 1.7 -2.0
3️⃣ >2.0
◼️ Kt/V ➡️NO INFLUENCE on survival
ncbi.nlm.nih.gov/pubmed/12846762
◼️ CCr ➡️ NO EFFECT on survival
◼️ Baseline UF ➡️ Associated with survival
ncbi.nlm.nih.gov/m/pubmed/14569…
◼️ Higher pCCr ➡️ NO EFFECT on survival
◼️ 1mL/min/1.73m2 🔼 GFR ➡️ 12% 🔽 mortality
ncbi.nlm.nih.gov/m/pubmed/12776…
◼️ Kt/V < 1.5/wk and pCCr <40L/wk/1.73m2 ➡️ 🔼RR of death
◼️ UF ➡️ 🔼survival
ncbi.nlm.nih.gov/m/pubmed/16105…
MIDAS
balANZ
IMPENDIA/EDEN
◼️ Icodextrin ➡️ safe, effective ⏩ can replace dextrose based solutions
ncbi.nlm.nih.gov/m/pubmed/79673…
Biocompatible solutions ➡️ NO role in GFR decline BUT
◼️ May delay anuria
◼️ 🔽Peritonitis
ncbi.nlm.nih.gov/pmc/articles/P…
Glucose sparing protocol ➡️
◼️ Improved metabolic indices BUT
◼️ 🔼Risk of ECFV expansion
ncbi.nlm.nih.gov/m/pubmed/23949…